Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating commercial sensors for clinical gait analysis

Official title: Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis in Adult Patients With Neurological Disorders

Run by Roessingh Research and Development · NCT05751408 · Data updated 2026-11-12

This study tests if commercial sensors can effectively measure walking patterns in adults with neurological disorders compared to standard clinical methods.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorRoessingh Research and Development
Academic / other
Locations1 site (Enschede)
StatusRecruiting
StartedJanuary 25, 2023
Main results expectedDecember 2028
Study endsDecember 2028
Registry record updatedMay 13, 2026
Trial IDNCT05751408 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with neurological disorders that affect walking, such as stroke, traumatic brain injury, or multiple sclerosis.

Probably not a fit

Patients referred for gait analysis due to issues unrelated to stiff knee gait or foot surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the usability of commercial Inertial Measurement Units (IMUs) for clinical gait analysis in adult patients with neurological disorders. Participants will undergo routine clinical 3D gait analysis using Vicon technology, while also incorporating IMU sensors to collect data on acceleration, gyroscope, and magnetometer readings from various body parts. The goal is to compare the performance of these commercial sensors against standard clinical methods, focusing on patients with conditions affecting their walking ability.

Why it matters

Potential benefit: If successful, this study could enhance the accuracy and efficiency of gait analysis in clinical settings, leading to better treatment plans for patients with neurological disorders.

How similar studies have gone: While the use of IMUs in sports and healthy individuals has been explored, this specific application in clinical gait analysis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Subjects referred for clinical gait analysis at Roessingh Centre for Rehabilition in Enschede, the Netherlands:

Inclusion Criteria:

* Disorders affecting walking, including amongst others stroke, traumatic brain injury, MS, incomplete spinal cord injury, CP, Spina Bifida, neuromuscular diseases
* age minimum 18 years
* Viosca score minimum 2; meaning minimal independent walking ability indoors
* increased fall risk or increased effort of walking because of: 1) decreased stability during stance; and/or 2) decreased foot clearance during swing; and/or 3) not able to walk on bare feet because of equinovarus; and/or 4) fatigue during walking because of compansatory strategies.

Exclusion Criteria:

* subjects referred for clinical gait analysis because of problems other than stiff knee gait or foot surgery
* severe deficits in communication, memory and understanding at such a level that it would affect instructions during the measurements

Where it's running

  • Roessingh Research and Development
    Enschede, Netherlands
    Recruiting

Study contacts

  • Principal investigator: C Nikamp, PhD — Roessingh Research and Development
  • Study coordinator: C Nikamp, PhD
  • Email: c.nikamp@rrd.nl
  • Phone: +31880875777

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.